US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eocene Ltd

4.03

-0.6000-12.96%

Post-market: 4.00-0.0300-0.74%17:29 EDT

Volume:190.69K

Turnover:887.32K

Market Cap:4.30M

PE:-0.29

High:4.88

Open:4.28

Low:3.89

Close:4.63

52wk High:13.20

52wk Low:3.29

Shares:1.07M

Float Shares:1.04M

Volume Ratio:2.72

T/O Rate:18.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.1059

EPS(LYR):-19.1292

ROE:--

ROA:--

PB:--

PE(LYR):-0.21

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)

Galmed Pharmaceuticals Rebrands as EoCene, Adopts NASDAQ Ticker EOCN

Galmed Pharmaceuticals: Rebrands as Eocene and Changes NASDAQ Symbol to 'Eocn'

THOMSON REUTERS

Press Release: Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "eocn" to Reflect Its New Dawn Platform for GI Innovation

Galmed Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Galmed Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGM

Galmed Pharmaceuticals Holds Annual Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/EOCN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EOCN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EOCN\",,,,,undefined,":{"symbol":"EOCN","market":"US","secType":"STK","nameCN":"Eocene Ltd","latestPrice":4.03,"timestamp":1789070400000,"preClose":4.63,"halted":0,"volume":190685,"hourTrading":{"tag":"盘后","latestPrice":4,"preClose":4.03,"latestTime":"17:29 EDT","volume":3044,"amount":12884.916246800001,"timestamp":1789075784142,"change":-0.03,"changeRate":-0.007444,"amplitude":0.186104},"delay":0,"changeRate":-0.12958963282937358,"floatShares":1041600,"shares":1068200,"eps":-14.105857,"marketStatus":"Post-Mkt","change":-0.6,"latestTime":"09-10 17:33:30 EDT","open":4.28,"high":4.88,"low":3.89,"amount":887315.387651,"amplitude":0.213823,"askPrice":4.7,"askSize":100,"bidPrice":3.92,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-14.105857,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"listingDate":1394683200000,"exchange":"NASDAQ","adjPreClose":4.63,"preHourTrading":{"tag":"盘前","latestPrice":4.1,"preClose":4.63,"latestTime":"09:28 EDT","volume":56600,"amount":264754.9617,"timestamp":1789046896260,"change":-0.53,"changeRate":-0.114471,"amplitude":0.688898},"postHourTrading":{"tag":"盘后","latestPrice":4,"preClose":4.03,"latestTime":"17:29 EDT","volume":3044,"amount":12884.916246800001,"timestamp":1789075784142,"change":-0.03,"changeRate":-0.007444,"amplitude":0.186104},"volumeRatio":2.723924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EOCN\",,,,,undefined,":{"symbol":"EOCN","floatShares":1041600,"roa":"--","roe":"--","lyrEps":-19.12916,"volumeRatio":2.723924,"shares":1068200,"dividePrice":0,"high":4.88,"amplitude":0.213823,"preClose":4.63,"low":3.89,"week52Low":3.2888,"pbRate":"--","week52High":13.2,"institutionHeld":0,"latestPrice":4.03,"committee":-0.333333,"eps":-14.105857,"divideRate":0,"volume":190685,"delay":0,"ttmEps":-14.105857,"open":4.28,"prevYearClose":6.004,"prevWeekClose":3.88,"prevMonthClose":4.12,"prevQuarterClose":4.4504,"fiveDayClose":4.119,"twentyDayClose":4.48,"sixtyDayClose":4.928},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EOCN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-03","symbol":"EOCN","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1788408000000,"reportTimeType":"post","actualEps":5.04},{"market":"US","date":"2026-08-19","symbol":"EOCN","defaultRemindTime":1787146200000,"type":"split","dateTimestamp":1787112000000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-07-08","symbol":"EOCN","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1783483200000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-03-31","symbol":"EOCN","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-11-26","symbol":"EOCN","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1764133200000,"reportTimeType":"pre","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EOCN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EOCN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EOCN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666895518","title":"Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666895518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666895518?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065605,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eocene (EOCN) and Dyne Therapeutics (DYN). Eocene (EOCN) Maxim Gr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eocene-eocn-and-dyne-therapeutics-dyn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4585","BK4139","BK4505","HCSG","BK4588","LABU","LU0128526141.USD","XLV","DYN","EOCN","XBI","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559580","title":"Galmed Pharmaceuticals Rebrands as EoCene, Adopts NASDAQ Ticker EOCN","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559580","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953512,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals rebrands as EoCene, adopts Nasdaq ticker EOCNGalmed Pharmaceuticals rebranded as Eocene, shifting its corporate identity toward a GI-focused biopharma and medical-device platfor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9QRKQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD","EOCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580372","title":"Galmed Pharmaceuticals: Rebrands as Eocene and Changes NASDAQ Symbol to 'Eocn'","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953488,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EOCN","GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580682","title":"Press Release: Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol \"eocn\" to Reflect Its New Dawn Platform for GI Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580682","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580682?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:30","pubTimestamp":1788953400,"startTime":"0","endTime":"0","summary":"-- Standby Equity Purchase Agreement  with YA II PN, LTD. . -- The Company has regained compliance with the minimum bid price. requirement set forth in Nasdaq Listing Rule 5550 and will continue. to be listed and traded on the Nasdaq Capital Market under the new ticker","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","GLMD","LCLG","NQmain","BK4139","GDOC","SEPA","HART","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665910321","title":"Galmed Regains NASDAQ Compliance with $1 Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2665910321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665910321?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:09","pubTimestamp":1788862160,"startTime":"0","endTime":"0","summary":"Galmed regains Nasdaq compliance with $1 minimum bid price ruleNasdaq notified Galmed on Sept. 3, 2026 that it regained compliance with the $1 minimum bid-price listing rule.Ordinary shares will remai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL7JMhhm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","EOCN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664575388","title":"Galmed Pharmaceuticals Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2664575388","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664575388?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:16","pubTimestamp":1788484561,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings SummaryGalmed Pharmaceuticals LtdGLMD.OQreported quarterly adjusted earnings of $2.86 per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL8N44W01N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EOCN","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664073708","title":"Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2664073708","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664073708?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:30","pubTimestamp":1788478208,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals ( ($GLMD) ) has issued an update. On September 3, 2026, Galmed Pharmaceuticals Ltd. held its Annual General Meeting of Share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-shareholders-approve-all-proposals-at-september-3-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-shareholders-approve-all-proposals-at-september-3-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801802","title":"Galmed Pharmaceuticals Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801802","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801802?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:10","pubTimestamp":1788466227,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals holds annual shareholder meetingGalmed held its annual general meeting of shareholders on Sept. 3, 2026.Shareholders adopted all proposals described in the meeting’s proxy mater","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3DdCkX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOCN","BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}